F. Sala

发表

Identification of phenyl-pyridine-2-carboxylic acid derivatives as novel cell cycle inhibitors with increased selectivity for cancer cells

I. M. Marks, L. Vassilev, Xuefeng Yin, 2002, Anti-cancer drugs.

Extracorporeal photochemotherapy reduces the incidence of relapses in experimental allergic encephalomyelitis in DA rats

G. Cavaletti, G. Tredici, F. Sala, 2001, Journal of Neurology.

Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drug.

F. Zunino, F. Sala, G. Pratesi, 1989, Chemico-biological interactions.

Bbr 2778, an Aza-anthracenedione Endowed with Preclinical Anticancer Activity and Lack of Delayed Cardiotoxicity

C. Manzotti, G. Pezzoni, F. Sala, 2001, Tumori.

Immunomodulating effects of extracorporeal photochemotherapy in rat experimental allergic encephalomyelitis.

G. Cavaletti, G. Tredici, F. Sala, 2001, International journal of tissue reactions.

Pixantrone (BBR2778) reduces the severity of experimental allergic encephalomyelitis

R. Rigolio, G. Cavaletti, G. Tredici, 2004, Journal of Neuroimmunology.

Cisplatin-induced peripheral neurotoxicity in rats reduces the circulating levels of nerve growth factor

G. Cavaletti, G. Tredici, G. Pezzoni, 2002, Neuroscience Letters.

Cell-based screening approach for antitumor drug leads which exploits sensitivity differences between normal and cancer cells: identification of two novel cell-cycle inhibitors.

I. M. Marks, L. Vassilev, S. Berthel, 2001, Anti-cancer drug design.

Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study.

G. Cavaletti, G. Tredici, G. Pezzoni, 2000, Toxicology letters.

Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells.

G. Cavaletti, G. Tredici, F. Sala, 2004, Journal of biological regulators and homeostatic agents.

Pixantrone (BBR 2778) has reduced cardiotoxic potential in mice pretreated with doxorubicin: Comparative studies against doxorubicin and mitoxantrone

F. Sala, L. Crippa, N. Oggioni, 2006, Investigational New Drugs.